Literature DB >> 18406616

The impact of p53 and p73 on aneuploidy and cancer.

Richard Tomasini1, Tak W Mak, Gerry Melino.   

Abstract

Initiation, progression and evasion are sequential steps in cancer formation, with autonomous cell proliferation as a final outcome. Genetic or epigenetic alterations of key regulatory genes of the cell cycle are frequently associated with these phenomena. Recently, chromosomal instability, a long-supposed driving force of tumorigenesis, was associated with dysregulation of mitotic genes, providing advantages to tumor cells. Numerous molecules thus provide a key link in the chain of relationships between chromosomal instability and cancer. Here, we discuss emerging evidence revealing that two p53 family members, p53 and p73, might be key regulatory genes at the heart of the relationship between chromosomal instability and cancer. We argue that the role of members of the p53 family as tumor suppressor proteins, their impact on the control of cellular ploidy, and their newly emerging connection with mitotic checkpoint regulatory genes support the suggestion that p73 and p53 could be two of the missing links among chromosomal instability, the mitotic checkpoint and cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18406616     DOI: 10.1016/j.tcb.2008.03.003

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  74 in total

Review 1.  The DNA damage-induced cell death response: a roadmap to kill cancer cells.

Authors:  Sonja Matt; Thomas G Hofmann
Journal:  Cell Mol Life Sci       Date:  2016-01-20       Impact factor: 9.261

2.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

3.  GLP overexpression is associated with poor prognosis in Chronic Lymphocytic Leukemia and its inhibition induces leukemic cell death.

Authors:  Juliana Carvalho Alves-Silva; Juliana Lott de Carvalho; Doralina Amaral Rabello; Teresa Raquel Tavares Serejo; Eduardo Magalhaes Rego; Francisco Assis Rocha Neves; Antonio Roberto Lucena-Araujo; Fábio Pittella-Silva; Felipe Saldanha-Araujo
Journal:  Invest New Drugs       Date:  2018-05-31       Impact factor: 3.850

4.  The p53 family: guardians of maternal reproduction.

Authors:  Arnold J Levine; Richard Tomasini; Frank D McKeon; Tak W Mak; Gerry Melino
Journal:  Nat Rev Mol Cell Biol       Date:  2011-04       Impact factor: 94.444

5.  Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck.

Authors:  Yang Zhang; Erich M Sturgis; Zhigang Huang; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

6.  Induction of apoptotic genes by a p73-phosphatase and tensin homolog (p73-PTEN) protein complex in response to genotoxic stress.

Authors:  Jason A Lehman; David L Waning; Christopher N Batuello; Rocky Cipriano; Madhavi P Kadakia; Lindsey D Mayo
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

Review 7.  20 years studying p53 functions in genetically engineered mice.

Authors:  Lawrence A Donehower; Guillermina Lozano
Journal:  Nat Rev Cancer       Date:  2009-09-24       Impact factor: 60.716

8.  BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD).

Authors:  Y Niikura; H Ogi; K Kikuchi; K Kitagawa
Journal:  Cell Death Differ       Date:  2010-01-08       Impact factor: 15.828

Review 9.  Ovarian cancer update: lessons from morphology, molecules, and mice.

Authors:  Kathleen R Cho
Journal:  Arch Pathol Lab Med       Date:  2009-11       Impact factor: 5.534

10.  Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression.

Authors:  George Hinkal; Neha Parikh; Lawrence A Donehower
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.